John Irwin III is listed as a director on 1 SEC Form D filing by 1 issuer in Feb 2016: TYROGENEX, INC. (Palm Beach Gardens, FL — biotechnology — 2016; $8.22M reported sold to 40 investors).
What this means One deal on file with the SEC, filed Feb 2016. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Adam Goodfriend (1 shared filing), Cheryl Calhoun (1 shared filing), Chris Liang (1 shared filing), Joseph Straight (1 shared filing), Michael Webb (1 shared filing) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.
The issuer belongs to the sponsor group Tyrogenex (2 issuers, $1.22M reported sold, 2011–2016).
What this means A sponsor group is one team that sets up a new company for each deal. Tyrogenex has 2 companies on file and $1.22M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 5 SEC releases, 4 bankruptcy cases matching the name listed in Key records below.
What this means 9 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for John Irwin III and found 6 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "John N. Irwin III" (CA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.